Bisphosphonate modulates cementoblast behavior in vitro

Journal of Periodontology

Volumn 76, Issue 11, 2005, Pages 1890-1900

  Chun, Yong Hee P ^a   Foster, Brian L ^b   Lukasavage, Patricia A ^a   Berry, Janice E ^a   Zhao, Ming ^a   Tenenbaum, Howard C ^c   Somerman, Martha J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bisphosphonate; Cementoblasts; Drug effects; Gene expression; Mineralization

Indexed keywords

3 NITROPHENOL; ALIZARIN RED S; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; SIALOPROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CEMENTUM; CONCENTRATION RESPONSE; DOWN REGULATION; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION REGULATION; IN VITRO STUDY; MINERALIZATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; TOOTH DEVELOPMENT; TRANSGENIC MOUSE;

ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; CALCIFICATION, PHYSIOLOGIC; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CEMENTOGENESIS; CORE BINDING FACTOR ALPHA SUBUNITS; DENTAL CEMENTUM; DOWN-REGULATION; ETIDRONIC ACID; MICE; MICE, TRANSGENIC; OSTEOCALCIN; OSTEOPONTIN; PHOSPHOPROTEINS; SIALOGLYCOPROTEINS;

EID: 28644433534     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.11.1890     Document Type: Article

References (57)

1. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003;423:349-355.
2. Fleisch H. Bisphosphonates in Bone Disease. San Diego: Academic Press; 2000.
3. Reddy MS, Weatherford TW, Smith CA, West BD, Jeffcoat MK, Jacks TM. Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol 1995;66:211-217.
4. Fleisch H, Russell RGG, Francis MD. Diphosphates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 1969; 165:1262-1264.
5. Goziotis A, Sukhu B, Torontali M, Dowhaniuk M, Tenenbaum HC. Effects of bisphosphonates ADP and HEBP on bone metabolism in vitro. Bone 1995;16:317S-327S.
6. D'Aoust P, McCulloch CAG, Tenenbaum HC, Lekic PC. Etidronate (HEBP) promotes osteoblast differentiation and wound closure in rat calvaria. Cell Tissue Res 2000;302:353-363.
7. Giuliani N, Pedrazzoni M, Negri G, Passed G, Impicciatore M, Girasole G. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vitro. Bone 1998;22:455-461.
8. Rogers MJ, Watts DJ, Russell RGG, et al. Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum. J Bone Miner Res 1994;9:1029-1039.
9. Sato M, Grasser W, Endo N, et al. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991;88:2095-2105.
10. Fisher JE, Rogers MJ, Halasy JM, et al. Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA 1999;96:133-138.
11. Benford HL, McGowan NWA, Helfrich MH, Nuttall ME, Rogers MJ. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 2001;28:465-473.
12. Frith JC, Mönkkönen J, Blackburn GM, Russell RGG, Rogers MJ. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 1997;12:1358-1367.
13. Benford HL, Frith JC, Auriola S, Mönkkönen J, Rogers M. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drug. Mol Pharmacol 1999;56:131-140.
14. Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 1997;100:1475-1480.
15. MacNeil RL, Berry J, Strayhorn C, Somerman MJ. Expression of bone sialoprotein mRNA by cells lining the mouse tooth root during cementogenesis. Arch Oral Biol 1996;41:827-835.
16. MacNeil RL, Berry JE, D'Errico J, Strayhorn C, Somerman MJ. Localization and expression of osteopontin in mineralized and nonmineralized tissues of the periodontium. Ann N Y Acad Sci 1995;760:166-176.
17. Takano-Yamamoto T, Takemura T, Kitamura Y, Nomura S. Site-specific expression of mRNAs for osteonectin, osteocalcin, and osteopontin revealed by in situ hybridization in rat periodontal ligament during physiological tooth movement. J Histochem Cytochem 1994;42:885-896.
18. Somerman MJ, Sauk JJ, Foster RA, Norris K, Dickerson K, Argraves WS. Cell attachment activity of cementum: Bone sialoprotein II identified in cementum. J Periodontal Res 1991;26:10-16.
19. Glimcher MJ, Lefteriou B, Kossiva D. Identification of O-phosphoserine, O-phosphothreonine and g-carboxyglutamic acid in the non-collagenous proteins of bovine cementum; comparison with dentin, enamel and bone. Calcif Tissue Int 1979;28:83-86.
20. Grzesik WJ, Kuzentsov SA, Uzawa K, Mankani M, Robey PG, Yamauchi M Normal human cementum-derived cells: Isolation, clonal expansion, and in vitro and in vivo characterization. J Bone Miner Res 1998;13:1547-1554.
21. Tenenbaum HC, Torontali M, Sukhu B. Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro. Bone 1992;13:249-255.
22. D'Errico JA, MacNeil RL, Takata T, Berry J, Strayhorn C, Somerman MJ. Expression of bone associated with markers by tooth root lining cells, in situ and in vitro. Bone 1997;20:117-126.
23. D'Errico JA, Berry JE, Ouyang H, Strayhorn CL, Windle JJ, Somerman MJ. Employing a transgenic animal model to obtain cementoblasts in vitro. J Periodontol 2000;71:63-72.
24. Franceschi RT, Iyer BS, Chi Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 1994;9:843-854.
25. Tenenbaum HC, Heersche JNM. Differentiation of osteoblasts and formation of mineralized bone in vitro. Calcif Tissue Int 1982;34:76-79.
26. Puchtler H, Meloan SN. Demonstration of phosphates in calcium deposits: A modification of von Kossa's reaction. Histochemistry 1978;56:177-185.
27. Puchtler H, Meloan SN, Terry MS. On the history and mechanism of alizarin red and alizarin red S stains for calcium. J Histochem Cytochem 1969;17:110-124.
28. Xie WQ, Rothblum LI. Rapid, small-scale RNA isolation from tissue culture cells. Biotechniques 1991; 11:324-327.
29. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 1997;89:747-754.
30. Young MF, Ibaraki K, Kerr JM, Lyu MS, Kozak CA. Murine bone sialoprotein (BSP): cDNA cloning, mRNA expression, and genetic mapping. Mamm Genome 1994;5:108-111.
31. Young MF, Kerr JM, Termine JD, et al. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 1990;7:491-502.
32. Celeste AJ, Rosen V, Buecker JL, Kriz R, Wang EA, Wozney JM. Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J 1986;5:1885-1890.
33. Lindskog S, Blomlöf L, Hammarström L. Cellular colonization of denuded root surfaces in vivo: Cell morphology in dentin resorption and cementum repair. J Clin Periodontol 1987;14:390-395.
34. Jin Y, Yip H- K. Supragingival calculus: Formation and control. Crit Rev Oral Biol Med 2002;13:426-441.
35. Sikder MN, Itoh M, Iwatsuki N, Shinoda H. Inhibitory effect of a novel bisphosphonate, TRK-530, on dental calculus formation in rats. J Periodontol 2004;75:537-545.
36. Francis MD, Slough CL, Briner WW, Oertel RP. An in vitro and in vivo investigation of mellitate and ethane-1-hydroxy-1,1-diphosphonate in calcium phosphate systems. Calcif Tissue Res 1977;23:53-60.
37. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 1999;104:1363-1374.
38. Francis MD, Russell RGG, Fleisch H. Diphosphates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 1969; 165:1264-1266.
39. Khairi MR, Altman RD, DeRosa GP, Zimmermann J, Schenk RK, Johnston CC. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. Ann Intern Med 1977;87:656-663.
40. Banerjee C, Hiebert SW, Stein JS, Lian JB, Stein GS. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 1996; 93:4968-4973.
41. Liu W, Toyosawa S, Furuichi T, et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 2001;155:157-166.
42. Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382:448-452.
43. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bone of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998;23:187-196.
44. Nociti FH, Berry JE, Foster BL, et al. Cementum: A phosphate-sensitive tissue. J Dent Res 2002;81:817-821.
45. Beck GR, Zerler B, Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA 2000;97:8352-8357.
46. Johnson K, Goding J, van Etten D, et al. Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res 2003; 18:994-1004.
47. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994;15:439-461.
48. Boskey AL, Spevak L, Paschalis E, Doty SB, McKnee MD. Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 2002;71:145-154.
49. Felix R, Graham R, Russel RGG, Fleisch HA. The effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymes. Biochim Biophys Acta 1976;429:429-438.
50. Leyhausen G, Lorenz B, Zhu H, et al. Inorganic polyphosphate in human osteoblast-like cells. J Bone Miner Res 1998;13:803-812.
51. Tenorio D, Cruchley A, Hughes FJ. Immnocytochemical investigation of the rat cementoblast phenotype. J Periodontal Res 1993;28:411-419.
52. Beertsen W, Niehof A, Everts V. Effects of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on the formation of dentin and the periodontal attachment apparatus in the mouse. Am J Anat 1985;174:83-103.
53. Lekic P, Rubbino I, Krasnoshtein F, Cheifetz S, McCulloch CAG, Tenenbaum H. Bisphosphonate modulates proliferation and differentiation of rat periodontal ligament cells during wound healing. Anat Rec 1997; 247:329-340.
54. Wesselink PR, Beertsen W. Ankylosis of the mouse molar after systemic administration of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP). J Clin Periodontol 1994;21:465-471.
55. Hammarström L, Lindskog S. Factors regulating and modifying dental root resorption. Proc Finn Dent Soc 1992;88:115-123.
56. Lindskog S, Blomlöf L, Hammarström L. Repair of periodontal tissues in vivo and in vitro. J Clin Periodontol 1983;10:188-205.
57. Wesselink PR, Beertsen W. The influence of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on dental root resorption in the mouse. Calcif Tissue Int 1989; 45:104-110.